key: cord-0856945-sl6x571e authors: Würnschimmel, Christoph; Maurer, Tobias; Knipper, Sophie; von Breunig, Franziska; Zoellner, Christian; Thederan, Imke; Huland, Hartwig; Graefen, Markus; Michl, Uwe title: Martini‐Klinik experience on prostate cancer surgery during the early phase of COVID‐19 date: 2020-05-18 journal: BJU Int DOI: 10.1111/bju.15115 sha: cda1f45974f3f33fa7ebb605b4a6618adf187599 doc_id: 856945 cord_uid: sl6x571e In order to restrain an uncontrolled spread of the 2019 Coronavirus‐Disease (COVID‐19) and to provide sufficient intensive‐care unit (ICU) capacity, medical specializations needed to develop new routines and risk‐strategy protocols. Those restrictions have also impacted the urologic community. Several medical organisations developed specific information‐hubs, blogs and resource centers on how to tackle the COVID‐19 situation (1–3). Although the German Society of Urology (“DGU”) has published a recommendation to evaluate the need for a timely therapy in prostate cancer (PCa) patients according to D’Amico risk groups on the 2(nd) of April 2020, up to now no compulsory directives exist regarding omitting radical prostatectomy (RP) during the COVID‐19 pandemic. In order to restrain an uncontrolled spread of the 2019 Coronavirus-Disease and to provide sufficient intensive-care unit (ICU) capacity, medical specializations needed to develop new routines and risk-strategy protocols. Those restrictions have also impacted the urologic community. Several medical organisations developed specific information-hubs, blogs and resource centers on how to tackle the COVID-19 situation (1) (2) (3) . Although the German Society of Urology ("DGU") has published a recommendation to evaluate the need for a timely therapy in prostate cancer (PCa) patients according to D'Amico risk groups on the 2 nd of April 2020, up to now no compulsory directives exist regarding omitting radical prostatectomy (RP) during the COVID-19 pandemic. The Martini-Klinik Prostate Cancer Center (MK) at the University Hospital Hamburg-Eppendorf (UHH) continued surgery for PCa under risk-adjusted special precautions. In this study, we share our initial experiences, routines and results of patients in the early COVID-19 phase. After approval of the study by the institutional review board, we performed a retrospective analysis of patient and preoperative tumor characteristics, as well as short-term complications of PCa patients undergoing RP at our institution before and during the early phase of the COVID-19 pandemic in Germany. One group represented a consecutive cohort of treated PCa patients since the first COVID-19 case at UHH was detected (27 th February 2020 -17 th April 2020), while the second Accepted Article group represented consecutive patients treated before the first event (1 st January -26 th February 2020). We evaluated possible short-term postoperative complications and circumstances which occurred in relation to COVID-19. Presumably predisposing factors for a potentially worse outcome in case of infection or increasing the probability to be depended on postoperative ICU care (focusing on patient age, cardiovascular disease and hypertension, obstructive sleep apnoea syndrome (OSAS), diabetes mellitus, chronic lung, kidney or liver disease and severe obesity) have been assessed by evaluation of patient history. All analyzed patients gave their informed consent for data-analysis. All clinical and patient data was stored in a secured and pseudonymized database in the MK. Within close communication to the official German public health institute "RKI" (Robert-Koch Institute) (4), a task force has defined the procedures and safety measures for all sections of the UHH, thus including the MK, since the first COVID-19 patient in Germany. Besides being physically "disconnected" from the main complex of the UHH and offering only one-and two-bed rooms, thus profiting from certain advantages in terms of infection control, further measures were established in the MK in concordance with the task force. Routinely, no COVID-19 testing was performed prior to surgery. However, before hospital admission and again prior to surgery, patients were repetitively asked about COVID-19 exposure or symptoms (see supplementary material). Patients with potential COVID-19 exposure were only admitted after a symptom free period of > 14 days and negative testing. Further COVID-19 measures of the UHH task force and the MK can be depicted in figure 1. Descriptive statistics of categorical variables focused on frequencies and proportions. Medians and interquartile ranges (IQR) were reported for continuously coded variables. For all statistical analyses R software environment for statistical computing (version 3.4.3) was used. All tests were two sided with a level of significance set at p <0.05. This article is protected by copyright. All rights reserved We have noted a slight decrease in the number of ICU transfers during the early COVID-19 phase (n = 19; median 2/week, IQR 0-2.25) compared to the pre-COVID phase (n = 26; median 3/week, IQR 2.75-3.25). The main reason for ICU transfers was a precautionary relocation, prompted by institutional standards of the anesthesiology department, in order to ensure monitoring for patients who were not assumed fit enough for the ward. Those relocations lasted only for the first postoperative night and retransfer to MK was arranged on the first postoperative day. Two patients during the COVID-phase however were relocated to the ICU due to Clavien IV complications (pulmonary embolism and hemorrhagic shock) Since no COVID-19 case occurred in our clinic during the early phase, we were unable to identify COVID-19 related complications in our patients. Moreover, we This article is protected by copyright. All rights reserved could not identify a connection to potentially concealed COVID-19 infections. Further short-term surgical complications are depicted in table 1. Our data is an excerpt to demonstrate the feasibility to continue surgery for PCa in a prepared surrounding. However, we acknowledge that the precautions and measures we have implemented within the MK might differ to other institutions or countries. This was mainly possible due to fact that the German health system and specifically the UHH provide an extraordinary hospital bed and ICU capacity, which gave a certain leeway especially in this early phase of COVID-19. Furthermore, the MK is in the special situation to be physically not connected to the main UHH complex of buildings and therefore, we were able to treat our patients in a reasonably protected surrounding. As we usually do not discharge patients before having them monitored for at least three days after surgery, we were able to recognize potential early COVID-19 related complications. If any signs of overstressing the UHH capacity had occurred, we would have taken the consequence to drastically decrease our activity. If necessary, the MK would have (and will) provide its bed-capacity to intercept a potential uncontrollable situation. Of note, we did not perform COVID-19 screening routinely but rather trusted in thorough and repeated assessment of patient history prior to admission to the clinic. Speaking of the general population, the RKI initially recommended testing only for patients with explicit symptoms and those with a very high risk of harboring COVID-19 (e.g. people in close contact to a confirmed case), while in later days, due to the increased availability of tests, recommendations are to test also mildly symptomatic persons. Very recently we decided to perform in-house reverse real time reverse transcription-polymerase chain reaction tests (RT PCR) for all patients admitted to MK prior to surgery. We are aware that this virus is unpredictable and therefore, most likely further adjustments of our actions have to be considered in the future in order to decrease the probability of a further spread and potentially avoidable complications or deaths. Although it is undisputed that cancer surgery cannot be postponed indefinitely, a certain delay in treatment of PCa due to the COVID-19 pandemic might not influence oncological outomes (3, 5) . Nevertheless, mainly due to the rapid roll of events during the early advent of the virus in Germany, we continued to perform surgeries for all Accepted Article risk-groups as most of these patients have already been diagnosed before and already enrolled on a waiting-list for a longer period. Therefore, we decided to continue to treat also patients with low-risk cancer in very fit patients and a life expectancy far beyond 10 years. However, in this scenario, reserving surgery for patients with more aggressive tumor features most likely finds the biggest agreement in the future, as this has also been advocated recently by the European Association of Urology (EAU) (3). Further surgical measures will be taken into consideration, such as the latest EAU Robotic Urology Section guideline advocating the reduction of potentially contagious airborne viral particles within the operating room (6). In the early phase of COVID-19, we experienced a favorable outcome of our patients, without having taken rigorous screening measures apart from a thorough patient history and by applying strict protective hygiene standards. We would like to thank all involved institutions which enable the MK to provide the necessary care to our cancer patients during the COVID-19 pandemic. Furthermore, we would like to distance ourselves of a general recommendation to commence surgery in other institutions or countries despite our favorable data. Nevertheless, we hope that our data contributes to a constructive discussion on possible future strategies within the medical community. World Health Organization BJUI COVID-19 Collection of Urology Papers EAU Guidelines Office Rapid Reaction Group: An organisation-wide collaborative effort to adapt the EAU guidelines recommendations to the COVID-19 era Group-An-organisation-wide-collaborative-effort-to-adapt-the-EAU-guidelinesrecommendations-to-the-COVID-19-era Coronavirus Disease 2019 (COVID-19) Daily Situation Report of the Robert Koch Institute Institute and the UHH task force.